From clinical markers to community support

The future of lupus treatment

Michael P. Madaio

Research output: Contribution to journalArticle

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system, for unknown reasons, becomes hyperactive and attacks normal tissue. SLE can affect any part of the body, but most often harms the joints, skin, lungs, blood vessels, kidneys cardiovascular and nervous systems. Dr Michael Madaio is a lead researcher in this area, seeking to improve the diagnosis and treatment of kidney disease in lupus patients. Dr Madaio was recently appointed the Section Chief of Nephrology and Kidney Transplantation in the Department of Medicine at Temple University School of Medicine, PA, USA. Previous to this he was a Professor at the University of Pennsylvania School of Medicine. Dr Madaio's main research area is the immunology of nephritis, in particular lupus nephritis and glomerular diseases. Here he discusses future directions in lupus diagnosis and treatment and the importance of providing support for lupus patients in the community.

Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalFuture Rheumatology
Volume2
Issue number3
DOIs
StatePublished - Jun 1 2007
Externally publishedYes

Fingerprint

Biomarkers
Medicine
Systemic Lupus Erythematosus
Lupus Nephritis
Nephrology
Nephritis
Kidney Diseases
Cardiovascular System
Allergy and Immunology
Human Body
Kidney Transplantation
Nervous System
Autoimmune Diseases
Blood Vessels
Immune System
Chronic Disease
Therapeutics
Joints
Research Personnel
Kidney

ASJC Scopus subject areas

  • Rheumatology

Cite this

From clinical markers to community support : The future of lupus treatment. / Madaio, Michael P.

In: Future Rheumatology, Vol. 2, No. 3, 01.06.2007, p. 247-250.

Research output: Contribution to journalArticle

Madaio, Michael P. / From clinical markers to community support : The future of lupus treatment. In: Future Rheumatology. 2007 ; Vol. 2, No. 3. pp. 247-250.
@article{aff7319cabaa429ab71960f6c362b004,
title = "From clinical markers to community support: The future of lupus treatment",
abstract = "Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system, for unknown reasons, becomes hyperactive and attacks normal tissue. SLE can affect any part of the body, but most often harms the joints, skin, lungs, blood vessels, kidneys cardiovascular and nervous systems. Dr Michael Madaio is a lead researcher in this area, seeking to improve the diagnosis and treatment of kidney disease in lupus patients. Dr Madaio was recently appointed the Section Chief of Nephrology and Kidney Transplantation in the Department of Medicine at Temple University School of Medicine, PA, USA. Previous to this he was a Professor at the University of Pennsylvania School of Medicine. Dr Madaio's main research area is the immunology of nephritis, in particular lupus nephritis and glomerular diseases. Here he discusses future directions in lupus diagnosis and treatment and the importance of providing support for lupus patients in the community.",
author = "Madaio, {Michael P.}",
year = "2007",
month = "6",
day = "1",
doi = "10.2217/17460816.2.3.247",
language = "English (US)",
volume = "2",
pages = "247--250",
journal = "Future Rheumatology",
issn = "1758-4272",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - From clinical markers to community support

T2 - The future of lupus treatment

AU - Madaio, Michael P.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system, for unknown reasons, becomes hyperactive and attacks normal tissue. SLE can affect any part of the body, but most often harms the joints, skin, lungs, blood vessels, kidneys cardiovascular and nervous systems. Dr Michael Madaio is a lead researcher in this area, seeking to improve the diagnosis and treatment of kidney disease in lupus patients. Dr Madaio was recently appointed the Section Chief of Nephrology and Kidney Transplantation in the Department of Medicine at Temple University School of Medicine, PA, USA. Previous to this he was a Professor at the University of Pennsylvania School of Medicine. Dr Madaio's main research area is the immunology of nephritis, in particular lupus nephritis and glomerular diseases. Here he discusses future directions in lupus diagnosis and treatment and the importance of providing support for lupus patients in the community.

AB - Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system, for unknown reasons, becomes hyperactive and attacks normal tissue. SLE can affect any part of the body, but most often harms the joints, skin, lungs, blood vessels, kidneys cardiovascular and nervous systems. Dr Michael Madaio is a lead researcher in this area, seeking to improve the diagnosis and treatment of kidney disease in lupus patients. Dr Madaio was recently appointed the Section Chief of Nephrology and Kidney Transplantation in the Department of Medicine at Temple University School of Medicine, PA, USA. Previous to this he was a Professor at the University of Pennsylvania School of Medicine. Dr Madaio's main research area is the immunology of nephritis, in particular lupus nephritis and glomerular diseases. Here he discusses future directions in lupus diagnosis and treatment and the importance of providing support for lupus patients in the community.

UR - http://www.scopus.com/inward/record.url?scp=34347384184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347384184&partnerID=8YFLogxK

U2 - 10.2217/17460816.2.3.247

DO - 10.2217/17460816.2.3.247

M3 - Article

VL - 2

SP - 247

EP - 250

JO - Future Rheumatology

JF - Future Rheumatology

SN - 1758-4272

IS - 3

ER -